Exelixis (EXEL) EBIT: 2010-2025
Historic EBIT for Exelixis (EXEL) over the last 16 years, with Oct 2025 value amounting to $236.5 million.
- Exelixis' EBIT rose 73.83% to $236.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $800.2 million, marking a year-over-year increase of 52.94%. This contributed to the annual value of $604.6 million for FY2025, which is 253.82% up from last year.
- Exelixis' EBIT amounted to $236.5 million in Q4 2025, which was up 10.75% from $213.6 million recorded in Q3 2025.
- Over the past 5 years, Exelixis' EBIT peaked at $275.9 million during Q2 2024, and registered a low of -$48.1 million during Q4 2022.
- For the 3-year period, Exelixis' EBIT averaged around $128.4 million, with its median value being $136.1 million (2024).
- Within the past 5 years, the most significant YoY rise in Exelixis' EBIT was 1,906.88% (2022), while the steepest drop was 140.74% (2022).
- Over the past 5 years, Exelixis' EBIT (Quarterly) stood at $118.0 million in 2021, then slumped by 140.74% to -$48.1 million in 2022, then skyrocketed by 270.12% to $81.8 million in 2023, then soared by 873.90% to $136.1 million in 2024, then skyrocketed by 73.83% to $236.5 million in 2025.
- Its EBIT was $236.5 million in Q4 2025, compared to $213.6 million in Q3 2025 and $186.9 million in Q2 2025.